UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

Annals of oncology, 2018-05, Vol.29 (5), p.1180-1188

2018

Volltextzugriff (PDF)

A clinically applicable molecular-based classification for endometrial cancers

British journal of cancer, 2015-07, Vol.113 (2), p.299-310

2015

Volltextzugriff (PDF)

Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery

Familial cancer, 2019-10, Vol.18 (4), p.429-438

2019

Volltextzugriff (PDF)

Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer

Gynecologic oncology, 2017-09, Vol.146 (3), p.596-602

2017

Volltextzugriff (PDF)

New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care

Gynecologic oncology research and practice, 2016-12, Vol.3 (1), p.14-14, Article 14

2016

Volltextzugriff (PDF)

97 Practicing knowledge translation: building awareness and assessing barriers and facilitators to provincial implementation of the proactive molecular risk classifier for endometrial cancer (ProMisE)

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A48-A48

2020

Volltextzugriff (PDF)

OP014/#480 Targeted molecular testing in endometrial carcinoma: validation of a restricted testing protocol

International journal of gynecological cancer, 2021-11, Vol.31 (Suppl 4), p.A16-A17

2021

Volltextzugriff (PDF)

749 Tumor cell dissemination is independent from endometrial carcinoma molecular subtypes

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A119-A120

2021

Volltextzugriff (PDF)

OP015/#492 Further stratification of no specific molecular profile (NSMP/P53WT) endometrial carcinomas to refine prognosis and identify therapeutic opportunities

International journal of gynecological cancer, 2021-11, Vol.31 (Suppl 4), p.A17-A17

2021

Volltextzugriff (PDF)

OP020/#524 Heath care resource and cost implications of integration of molecular classification in the management of endometrial cancer

International journal of gynecological cancer, 2021-11, Vol.31 (Suppl 4), p.A19-A19

2021

Volltextzugriff (PDF)

OP008/#194 P53ABN molecular subtype encompasses a morphologically diverse subset of endometrial cancers and identifies therapeutic opportunities to improve outcomes

International journal of gynecological cancer, 2021-11, Vol.31 (Suppl 4), p.A14-A14

2021

Volltextzugriff (PDF)

Prenylated Flavonoids from Morus alba L. Cause Inhibition of G1/S Transition in THP-1 Human Leukemia Cells and Prevent the Lipopolysaccharide-Induced Inflammatory Response

Evidence-based complementary and alternative medicine, 2013-01, Vol.2013 (2013), p.1-13

2013

Volltextzugriff (PDF)

Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A37-A37

2019

Volltextzugriff (PDF)

Molecular classification of endometrial carcinoma across Canada: Variation in practice and opportunities to move towards consistency of care

Gynecologic oncology, 2020-10, Vol.159, p.241-242

2020

Volltextzugriff (PDF)

3 Translating endometrial molecular risk stratification to endometrioid ovarian carcinoma: a novel application of precision medicine

International journal of gynecological cancer, 2019-09, Vol.29 (Suppl 3), p.A2-A3

2019

Volltextzugriff (PDF)

382 Molecular classification of endometrial carcinoma substantially changing risk-assessment: Results from a european multicentre initiative

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A87-A88

2021

Volltextzugriff (PDF)

6 Interpreting immune infiltrates and hormone biomarkers in young women with endometrial carcinoma (EC) through a moder lens (POST-TCGA) of molecular classification

International journal of gynecological cancer, 2019-09, Vol.29 (Suppl 3), p.A4-A4

2019

Volltextzugriff (PDF)

6 Variation in practice in endometrial cancer (EC); can molecular classification direct care and reduce costs associated with management?

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A5-A5

2020

Volltextzugriff (PDF)

454 Study in progress: international retrospective study on lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease (LEOPARD)

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A188-A189

2020

Volltextzugriff (PDF)

Dialogues on Decolonial Participatory Design Praxis During a Revolution

Proceedings of the Participatory Design Conference 2022 - Volume 2, 2022, p.52-57

2022

Volltextzugriff (PDF)

Small bowel herniation around an anterior gastropexy for a gastric volvulus: a case report

Journal of the Society of Laparoendoscopic Surgeons, 2000-07, Vol.4 (3), p.271-273

2000

Volltextzugriff (PDF)

Implications of Synchronous IVR Radio on Syrian Refugee Health and Community Dynamics

Proceedings of the 8th International Conference on Communities and Technologies, 2017, p.193-202

2017

Volltextzugriff (PDF)

L1CAM to further stratify endometrial carcinoma patients with nonspecific molecular risk profile

Geburtshilfe und Frauenheilkunde, 2018, Vol.78 (10)

2018

Volltextzugriff (PDF)

Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock

The Lancet (British edition), 1999-10, Vol.354 (9188), p.1446-1447

1999

Volltextzugriff (PDF)

Social dreaming together: A critical exploration of participatory speculative design

Proceedings of the Participatory Design Conference 2022 - Volume 2, 2022, p.147-154

2022

Volltextzugriff (PDF)

1 – 25 von 543

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(371)
Mit Volltextzugriff
(405)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(243)
Life Sciences & Biomedicine
(179)
Humans
(90)
Female
(79)
Biological And Medical Sciences
(47)
Animals
(46)
Oncology
(46)
Physical Sciences
(45)
Mathematics
(39)
Lebanon
(36)
Fundamental And Applied Biological Sciences. Psychology
(35)
Endometrial Cancer
(31)
Mathematics, Applied
(27)
Breast Cancer
(25)
Cancer
(25)
Mice
(23)
Tumors
(23)
Mutation
(21)
Middle Aged
(20)
Prognosis
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

A clinically applicable molecular-based classification for endometrial cancers

Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery

Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer

New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care

97 Practicing knowledge translation: building awareness and assessing barriers and facilitators to provincial implementation of the proactive molecular risk classifier for endometrial cancer (ProMisE)

OP014/#480 Targeted molecular testing in endometrial carcinoma: validation of a restricted testing protocol

749 Tumor cell dissemination is independent from endometrial carcinoma molecular subtypes

OP015/#492 Further stratification of no specific molecular profile (NSMP/P53WT) endometrial carcinomas to refine prognosis and identify therapeutic opportunities

OP020/#524 Heath care resource and cost implications of integration of molecular classification in the management of endometrial cancer

OP008/#194 P53ABN molecular subtype encompasses a morphologically diverse subset of endometrial cancers and identifies therapeutic opportunities to improve outcomes

Prenylated Flavonoids from Morus alba L. Cause Inhibition of G1/S Transition in THP-1 Human Leukemia Cells and Prevent the Lipopolysaccharide-Induced Inflammatory Response

Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?

Molecular classification of endometrial carcinoma across Canada: Variation in practice and opportunities to move towards consistency of care

3 Translating endometrial molecular risk stratification to endometrioid ovarian carcinoma: a novel application of precision medicine

382 Molecular classification of endometrial carcinoma substantially changing risk-assessment: Results from a european multicentre initiative

6 Interpreting immune infiltrates and hormone biomarkers in young women with endometrial carcinoma (EC) through a moder lens (POST-TCGA) of molecular classification

6 Variation in practice in endometrial cancer (EC); can molecular classification direct care and reduce costs associated with management?

454 Study in progress: international retrospective study on lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease (LEOPARD)

Dialogues on Decolonial Participatory Design Praxis During a Revolution

Small bowel herniation around an anterior gastropexy for a gastric volvulus: a case report

Implications of Synchronous IVR Radio on Syrian Refugee Health and Community Dynamics

L1CAM to further stratify endometrial carcinoma patients with nonspecific molecular risk profile

Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock

Social dreaming together: A critical exploration of participatory speculative design

Suchergebnisse filtern